Sunshine Biopharma Inc. 10-Q

ITEM 5. OTHER INFORMATION   None.     24     ITEM 6. EXHIBITS   Exhibit No.   Description       31.1   Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002         31.2   Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002         32   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   101.INS   XBRL Instance Document* 101.SCH   XBRL Schema Document* 101.CAL   XBRL Calculation Linkbase Document* 101.DEF   XBRL Definition Linkbase Document* 101.LAB   XBRL Label Linkbase Document* 101.PRE   XBRL Presentation Linkbase Document* ______________________ * Pursuant to Rule 406T of Regulation S-T, these interactive data files are not deemed filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act or Section 18 of the Securities Exchange Act and otherwise not subject to liability.     25     SIGNATURES   Pursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on May 11, 2021.     SUNSHINE BIOPHARMA, INC.             By: s/ Dr. Steve N. Slilaty       Dr. Steve N. Slilaty,       Principal Executive Officer                     By: s/ Camille Sebaaly       Camille Sebaaly, Principal Financial Officer and       Principal Accounting Officer         26